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ABOUT THE IPTS REPORT
tl be tm Rqport uas launched in December 1'995, on the request and under tbe auEices of
I Colntnissioner Cresson. Wat seerned like a daunting cballmge in late 1995, nou 4ppears in retrospect
as a crucial galuaniser of tbe IPN' mergies and skilk.
Tbe Report bas publisbed articles in nurnerous areas, maintaining a rougb balance between tbem, and
exploiting interdisciplinarity as far as possible. Articles are deemed propc?iuely rebuant if they anempt n
acplore issues nat yet on tbe policynakerl agenda (but projected to be tbere sooner or later), or
underappreciated aspcts of issues already on tbe policymaker\ agmda. Tbe long drafting and redrafiing
procgss, based on a series of interactiue consultations uitb outside etcperts, guarantea quality control.
Tlte clearest indication of tbe r@rt's success is tbat it is being read. An initial print run of 2000 for tbe fi*
issue (00) in December 1995 looked optirnistic at tbe tine, but issue 00 bas since tumed into a collector's
item. Total readenbip rose to around 10,000 in 1997, aitb readet continuing to be drawnfrom o uariety
of batkgrounds and regions world-wide, and in 199t] a sbifi in empbasis touards the elecnonic uercion on
tbe \Veb has begun.
Tlte laurek tbe publication is reaping are rmdering it attractiue Ior autborc from outside tbe Corwnissian.
Ve baue already publisbed contributions by autborsfrom sucb lenomed institutions as tbe Dutcb TNO, tbe
German WI, the ltalinn ENEA and the US Council of Strategic and International Studies.
Moreoue4 the IPN formally collaborates on the production of tbe IPTS Rqort uitb a group of prestigious
European institutions, aitb ubotn tbe IPIS bas formed tbe European Science and Tecbnologlt Obsenatory
(ESTO), an irnportant pan of tbe renit of tbe IPTS. Tlte IFIS Report is tbe most uisible manifestatio:n of tbis
collaboration.
Tbe Report is produced. simultaneously in four languages (EnglLsb, French, German and Spanisb) by tbe
IPTS; to these one could add tbe ltalian translntion uolunteered by ENEA: yet anotber sign of tbe Report s
increasing uisibility. Thefoct tbat it is not only auailable in seueral languages, but also largely prqared and
produced on tbe Internet World \Vide Web, rnakes it quite an uncornmon undertaking.
We sball continue to endeauour to find the best uay of fulf;.iling tbe etLpectations of our quite diuetse
readercbip, auoiding ouercimplificetion, as well as encyclopaedic reuiews and tbe inaccessibility of academic
journals. Tbe key is to remind ourcelues, as well as the readers, tbat we cannot be all tbings to all pople, tbat
rt is inportant to carue out our nicbe and continue optimatty exploring and exptoiting it, hoping to
illuminate topics under a new, reuealing ligbt for tbe bmeflt of the readers, in order to prqparc tbem for
tnanaging tbe cballenges abead.
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P ref cLce
bfu dpecial itduz of 'Tbe IPTS Report" hat been ?evote?
reuarcb retultt a?Iruaing partbukr cotuuffur concerru,
or?er to empba.abe my peruonal commitmznt an7 tbat of the European
Commitdi"on to better derve tbe European citizcn.
Witb tlae progredd of acicntifb knnwtc?ge over recent ?eca?ed, onc cAn now
expect to probe more ?eeply tbe quzdtiona turcoun?ing tlae pro?urtion of
foo?, tlae treatmznt o/?iteant, an? tbe duttainablz managemcnt an? ude
of natural relourced. One can abo anticipate clarfuing tbeir impact on
cotrJutTur ncelt, in?uttrial practiced an? policy contQerationt,
One of tbe ?riuing forcea of tbe 5tb Framzwork Programmz /or RdTD
pill be to belp a??redd tbe nce?d o/ dociety an? to mzet t/ee requiremzntd
o/ t/ae coruunur lzaAing to /uture weah/e an? job creatiory whilc
redpecting tbe principlzt of auttaina^bb ?evelopmznt. T/ee approacb in the
contaxt of a?7reading cotrrutrrcr concenu will be tofocut on apecifir areal
pbere redearcb can potentially prouhe technbal aruperu to nmz o/ t/ae
preddlng quedtiont, wbir/e woull but be tacklz7 at a European lcvel.
lWoreove7 t/ae Joint Rcdearcb Centre of tlee European Commitdion,
u,/zode workprogrammz alrea?y inchfued a dpecific linc of actbn ?evote?
to the cotaunur protection area, bat create? tbe Inttitutefor Heahb an?
to
in
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Contumzr Protection. Tbil ncw itutitute will enbance tbe dcizntifi"c an7
tecbnical knowlc?ge aeaikble to tlae EU Commiadi"on urvicea an? to all
t4emler Stated autboritied on bazar?a an? ritkt, cauae? by pro?ucta an?
proceller of variout kin?d, to wleicb tlae European citizen it enpode?.
Tbe European Commfution ia paving tbe way towar?a a genuine
'European reaarcb area', wbere European kboratorbt, univeraitiea an?
companiu ?epote a aignficant part of tbeir rerourcer to protect tbe
cotuunuf in otber por?d to promote European reuarcb at tbe rcrvi.ce of
tbe citizen an? European competitiuenett in a globalframzwork.
,J .J 
-J .J .J
@ IPTS - JRC - Seville. 1998
No 50 December 1998 The IPTS Report
TI{E IPTS REPORT sTNETNoc
;1.1,,1:':;:,,
:..:aa:r:r:
i.,l;..,
.t:,::;:
o i'?"t m s
''':
':t,),L:,
ER
..:1.at
1998
EDTTED BY THE INsIIruft FOR PROSPECI1VE
TECHNOLOGICAL SruDES OPIS)
And issued in Cooperation wifi
the European s&T observatory Network
PUBLISHED BY THE EUROPEAN COMMISSION
Joint Research centre
ISSN:1025-9384
Cablogue Number CK-AA-98{1o-EN-C
DEPOT TEGAL: SE-1937-95
DIRECTOR
Jean-Marie Cadiou
EXECUTIVE EDITOR
Dimifis Kyrhkou
EDITORIAL BOARD
G. Fahrenkog, P Fleissner, J. oavigan,
M. Conz6lez, H. Hemandez, D. Kyri*ou, L Maghiros
(Production Managen, P.sgrup, A" Soria, C. Tahir.
PRODUCTION
crNDoc-csrc/cl s€Fvrcros uNc0lsllc6
PRINT
craesal
TRANSLATION
crNDoc-csrc/cl sERvlcros uNoulsT|cos
coPvllGllT
The views expressed in tiis publkatjon do not
neoessarily r€flect those of the European Commission
o Ecsc-EEc-EAEC Brusseb-Luxembourg. 1997
Reproduction is autiotised, excefi for commercial
purposes, provided the source is acknowledged.
fhe EC mey not be held responsible for the use
made of tie informatbn.
t||t lP?s REPOIT
is published in the first week of every monti, except
for the months of January and Au$lsl lt is edited in
English and is cunentt available at a price of 50 EcU
per )€ar, in four languages: English, French, G€rman
and spanish.
suEscrrPlrot3
For a sub6cription to lhe IP-TS Report,
or to amend an existing subsctiption, please
wlte with full details tol
the lP-B Report Secrebriat
rPrs. JRc sdilla
World Trade Center
lsla de h Cartqia
E-41092 sevilla, sp:in
lel +u-95-489297
Fax: +54-95-4rE 82 93
E-mail: ipb_secr@jrces
web address: wwwjrc.eyipBreporysub6cribe.hgnl
'.JCT,J
@ IPTS - JRC - Seville, 1998
SPECIAL ISSUE: RESEARGH AIID OOilSUilER ISSUES
Edltorlal
6 Th€ tnstltute for Health and consumer Protectlon: A ilew JRc
hstltute s€rylng European Cltlzens
Under the EU Fifth Framework Programme for research the IHCP will be responsible for a
range of health and consumer concerns as part of the overall aim of serving Europe's citizens.
Its aim will be to provide the scientific and technical expertise necessary to give policy
makers independent advice on issues relating to food, pharmaceuticals, chemicals, etc.
9 lmproylng Consumer Protectlon: Slpport for Food Contnol
Consumer confidence depends not only on proper labelling but also on the fact that this is
backed up by adequate controls to avoid food+elated fraud. The JRC, in conjunction with
other centres across Europe, is working on developing the necessary analytical methods and
dissemination of both techniques and test data to the food laboratories responsible for controls.
15 Future Technoloeles, changlng contum€r Declslons and tabelllng
Requlren€nts
The range of products available to consumers is constantly increasing, sometimes making
choices harder, particularly in view of growing health concerns about food. Labelling will
only be a help if it gives consumers the information they want in a way they can interpret,
and this requires the engagement of all stake-holders as well as efforts to raise awareness
and educate consumers.
20 Blotechnology and H€alth care: consum€r-R€lated Asp€Gts
, The various technologies included under the rubric of biotechnology are likely to have a
major impact on the health care market in the coming years. As new products become
available issues relating to assessing their worth and how to channel demand will become
yet more pressing.
26 Th6 Supply of hformatlon to th€ consumer: when tor€ ls Actually L€ss
In the electronic market place consumers are using increasingly sophisticated tools to find
products matching their requirements whilst retailers are using more sophisticated ways to
profile their target customer groups. The overload of information for online consumers in a
rapidly expanding Web market and concerns about the protection of data being gathered
about them are two of the issues raised.
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EDITORIAT
Fabiana Scaoolo and Anette Schmitt
esearch and the accumulation of
knowledge concerning the impact of
technology on consumer issues are
important factors for policy makers to
take into account in this area.
This special issue of The IPTS Report is
an introductory presentation of the citizens
orientation of European research policy as
prominently featured in the Fifth Research
Framework Programme of the EU Commission.
In October 1998, the Joint Research Centre
flRC) of the European Commission set up the
Institute for Health and Consumer Protection
(IHCP) in ltaly. This special issue on Sfi and
consumer issues is partly a response to this
institutional innovation, whose mission is to
increase the scientific and technical knowledge
of EU Commission services and of Member States
Authorities on hazards, exposure and risks,
caused by products and processes of various kinds
and to which European citizens may be exposed.
The first two articles of this special issue present
the activities of this new institute.
While the value of information has risen, the
cost associated with the time needed to become
well informed has also increased. With the
enormous proliferation of product alternatives,
information has become ever more important to
consumers. The private and public benefits from
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truth in labelling and advertising imply therefore a
continued role for EU regulation of information
about the attributes of consumer goods. With the
increasing use of health as a marketing tool, the
amount of nutritional information on food labels,
for instance, has sharply increased in recent years.
One article of the report therefore discusses
nutrition labelling, which has recently become
mandatory on processed foods within the
European Union but which continues to be one of
the most high profile and controversial aspects of
food legislation. In response to this debate, the
Commission has launched in October 1998 a
"European food safety campaign" which is to run
in all 15 European Union countries.
Among the practical tools for implementing
labelling, control laboratories in all Member
States are expected to use harmonized and
validated methods, analytical standards and
mutually recognized approaches to analytical
quality assurance. One article argues therefore
that it is essential to devote adequate financial and
scientific resources to the necessary practical
measures needed to bring this about and to enable
control laboratories for effective enforcement of
safety and labelling regulations.
The next article focuses on the ootential
biotechnology has to produce wide-reaching
social and economic impacts. In fact, the ever
increasing range of potential applications opening
,1,';,4
.l it
irir'
,J,J,Jtt
@ IPTS - JRC - Seville, 1998
No.30 December 1998
up to biotechnology suggest it is likely to pervade
many aspects of life in the future, also by
improving the quality of life in many areas. ln
particular, an accelerated rate at which new
pharmaceutical projecr could become available
may require policy responses in a number of areas.
The final article deals with the impact of novel
Internet-based technologies used to identify high-
quality products, better services and prices.
Gradually consumers are becoming more
qualified in gathering and analysing market
related information in the shortest time with the
effect that too much information to scan
through makes selecting more difficult. Targeted
advertising raises questions of privacy rights and
moral concern about how information should be
used. Measures ought to be studied that would
The IPTS Report
educate the consumer early on, as to how to
combat Information Overload, as well as keep an
eye on key actors and the way in which they
might exploit thelr dominant market position.
Finally, the citizen is the focus of many
EU activities. On 22 September 1998, seven
Directors General (i.e. DCs V X, XV XVl, XXll,
XXlll, and XXIV) signed the agreement on a major
information initiative'Europe Direct, Permanent
Dialogue with Citizens and Business'. 'Europe
Direct' is a service that aims giving a user-friendly
direct access to information and advice about the
European Union and citizens' rights in the Single
Market. This service will operate in all Member
States through the Web and free phone numbers,
whereby the public will be allowed to submit
queries and receive replies in their own language.
-J-J'-J.J
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Consumers are
potentially at risk from
many sources;food,
drink, cosmetics, etc.
And apart from health
risks, countenfeit or
adulterated goods may
have negative effects
on the quality of life
No 50 December 1998
The lnstitute for Heatth andConsumer Protection: A New JRCInstitute serving European Citizens
Livio Manes, IHCP
lssue: The Jolnt Research centre uRc) of the European commlsslon has recenfly been
supplemented by a new Instltute, the Instltute for Health ancl consumer protecflon
(lHcP). The mlssion of the lHcP ls to Increase the sclentific and technlcat knowledge
among EU Commlssion servlces and the relevant authorities ln Member states
concernlng hazards arislng from proclucts ancl processes of varlous klnds to which
European Cltlzen's are potenflally exposed.
Relevance: The duty to "serve the cltlzen" guldes the pollflcal anct leglslaflve acflon of
the European Commlssion, Insplrlng pollcles meant to address the lssue of dangerous
envlronments, products and events whlch may jeoparcllse health and quallty of llfe.
The scope of the lHcP ls to help these pollcles, by means of sctentific and technlcal
support actions.
Analysls centre of science and technology of the Union",
i.e. an institution providing sound EU-policy
oriented research supporting the management of
change in our society.
Among their everyday purchases consumers
may happen to come into contact with substances
which, for one reason or another, pose a threat to
their health. Such substances may form part of
food, drink, cosmetics, and even ornaments. This
can have serious consequences, especially for
children. Also, the marketing of non-prescription
drugs or inadequately defined chemicals can
constitute a threat. Even without immediate
damaging consequences to health, counterfeit or
adulterated products may fail to live up to
consumer expectations and even have negative
effects on the quality of life. With the increasing
,JT5J,J
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he field that IHCP is called uoon to
monitor and explore is very broad. lt is
important for Europe to have a structured
and predictable health and consumer
protection system (with the repercussions this may
have on trade). In fact, the image of the European
Union has not only to be defended, but also
enhanced given its role as one of the "trademarks"
of our European culture.
Though the field is wide, the IHCP must find
the best way to employ its resources for this
purpose. The fact that the IHCP is part of the
Joint Research Centre (JRC) of the European
Commission is an important feature. The mission
of the JRC was defined as being "the reference
No.30 December '1 998
impact of biotechnologies in agriculture and in
food production, it is essential to ensure
genetically modified organisms (CMOs) do not
give rise to unacceptable hazards resulting from
their deliberate or accidental propagation. But
also, the consumer needs to be helped to perceive
promising and highly beneficial technologies
correctly in order to make informed judgements. In
all these examples, scientific and technical support
means performing careful analysis of the products
and their compatibility with the biosphere, and
this involves assessing not only immediate risks
but also the long-term consequences of a
prolonged exposure. Another interesting research
avenue being pursued is cellular testing, which
seems to offer a promising biotechnological tool to
reduce the need for costlv and less ethicallv
acceptable animal testing.
Health needs to be enhanced by making
available advanced methods for diagnosis and
therapy, especially for the early detection and
treatment of widespread diseases such as cancers,
cardiovascular diseases, and neurological
disorders. There is a need to harmonize and
increase the reliability of most medical methods as
well as to make it possible for citizens and health-
care services to support their cost. The present
abundance of biocompatible body inserts and
implants, for instance, calls for studies on their
reliability and on their expected lifetimes.
Both policy makers and the public should be
constantly kept abreast of current and emerging
issues in these fields, whilst seeking to avoid
sensationalism. Hence, there is a need for
an accredited database containing critical
assessments produced by the competent European
Authorities. Europeans need to see these
assessments backed by the scientific and technical
support of a body of scientists which is
independent of commercial and national interests,
and this is a role which the IHCP aims to play.
,J',J-J,J
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The miSion of the IHCP must be achieved
through thq commitment of its entire staff, who
need to bri4g their expertise and skills to bear on
their two nirain functions. On the one hand, the
IHCP must fulfil its role as a Commission
service mpintaining constant and dynamic
communic{tion with policy makers: these include
EU Directoiates Ceneral as well as the National
Regulatory ] and Healthcare Organizations and
Industries irt the Member States. The IHCP's work
programmei must therefore be demand-oriented
and its actiVities must always be well attuned to the
EU political agenda in its fields. On the other hand,
the InstitutQ needs to be recognized by the S&T
communityi in Europe as a highly reputed partner
and is work requested for collaboration in and co-
ordination lwith extensive networking. This will
underwritel the IHCP's credibility and gain
acceptancg for it as an indispensable link to the
EU decisiQn-making process for all technical
problems. llherefore, the IHPC must be able to
demonstratb its scientific and technical excellence
and its abflity to judge emerging products and
systems. Tfie fact that it hosts a multidisciplinary
team of scibntists and technicians ensures it has the
high qualitv, flexibility, and scientific credibility
necessary tb represent the interests of the citizens of
the Union, iand also the ability to form an important
part of the lramework of the much larger and highly
qualified interdisciplinary environment of the
European rhientific and industrial comnrunity.
The IHCP's mission requires it to respond in a
flexible anil appropriate way to demands as soon
as they afise and also for it to participate in
ongoing sLientific and technical developments.
This can only be achieved if an adequate research
effort is uriCertaken at the lnstitute. Obviously, this
research hannot cover all aspects of these
complex ffelds. Rather, a selective effort must be
made so ds to obtain maximum benefit from the
particularlskills, which are present in, or can be
acquired $y, the Institute.
The lPTs Report
Health needs to be
protected bV making
available advanced
diagnostic and
therapeutic methods,
especially for the
early detection and
treatment of
widespread diseases
The Institute for
Health and Consumer
Protection is intended
to meet these needs
by offering technical
and scientific expertise
independent of
particular commercia
and national interests
The new institute will
channel and develop
existing activities
created under the
Fourth Framework
Programme. Also, it will
work in collaboration
with other institutes
under the umbrella
of the JRC
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The IPTS Reoort
Food unit and two
dedicated information
units: "support to
Pharmaceutical
Regulatory Activities"
and the European
Chemical Bureau
('ECB" Unit)
About the author
Livio Manes is a physical
chemist and has worked
at the University of Rome
and the University of
Michigan. He has worked
at the JRC since '1964
where he is unit head of
the lnstitute for Advanced
Materials and advisor to
the Director of the
Institute for Consumer
Protection and Heath and
is responsible for its
general strategy under
the Fifth Framework
Programme. He has also
carried out research
for the ITU (lnstitute
for Transuranium
Elements) in solid state
physics, theoretical
thermodynamics, and
nuclear technology.
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ln the Fifth JRC Framework Programme the IHCP
is set entirely within Action l, "Serving the citizen".
The IHCP does not stand alone but is envisaged as
forming part of a cluster with other JRC Institutes. ln
particular, the IHCP will collaborate with the IPTS,
which will provide a forward looking, policy
relevant assessment of forthcoming issues of
relevance for consumer protection, as well as rapid
ad hoc emergency support to Commission services
drawing on the expertise of the IHCP. Furthermore,
the new institute has not been born in a vacuum,
most of its activities in fact stem from work
already started as institutional and/or competitive
support to Commission activity during the Fourth
Framework Programme.
The IHCP Food Unit has comoetence for
the analytical chemistry necessary to examine
consumer-product safety and quality. lt continuously
develops new validation methods, through
comparison, confrontation and inspection of results
within appropriately constructed European network
and it has started action in the field of genetically
modified organisms (CMOs). The European Cenhe
of Validation of Alternative Methods (or "ECVAM"
Unit) is a laboratory of recognized prestige
performing research on biocompatibility and on the
issue of substituting animal testing with cellular
testing strategies. The "Biocompatible Materials and
Cyclotron Unit" provides a necessary background in
physics, physical chemistry numerical modelling
and design engineering.
Finally, the two dedicated information
Units - "Support to Pharmaceutical Regulatory
No 30 December 1998
Activities" and the European Chemical Bureau
("ECB" Unit) 
-manage the link between the
database and policymakers, not only from a
technical view point, but also in the general
framework of consumer policy.
Outlook
The IHCP's existing potential already includes
a significant share of the disciplines needed for its
work and this may be complemented with other
areas through networking. Teething problems may
naturally arise when integrating so many different
interests, cultures and languages. Nevertheless it
is the IHCP's task to overcome them, and it is
confident of being able to do so within the Fifth
Framework Programme. The IHCP is aware that
only in this way will it be able to provide the
European Commission with the high quality,
flexible, coherent, (albeit small) scientific force
that Europe deserves. In the long-term its scope
will take in the monitoring, and where possible
reduction, of health hazards and so it will come
to play a part in improving the quality of life.
To do this its status as a European Commission
body, independent of commercial and national
interests, is essential. In addition, the IHCP work
programme is demand-driven, responding to the
needs of society, and to support EU policies.
This can be achieved through dialogue with
national and international regulatory authorities,
biomedical industry players, and networking with
the medical world. This new shared mission
defined for the JRC will also be the hallmark
of inis new Institute. 5
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Dr. Livio Manes, IHCP
Tel.: +39 0332789028, fax: +39 0332789 169, e-mail:livio.manes@jrc.it
IPTS Contact
Ms. Fabiana Scapolo, IPTS
Tel.: +34 95 448 82 91, Iax: +34 95 448 82 35, e-mail: fabiana.scapolo@jrc.es
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lmproving Consumer Protection:
Support for Food Control
Elke Anklam, JRC, John cilbert, csL Food science LaboratorY (uK)
Issue: There ls a need to support food control In the EU and to ensure that the practlcal
tools for implementlng regulatlons are available to control laboratories in all Member
states. The necessary'tools of the trade' are valiclated methods, analwical standards and
mutually recognlzed approaches to analwcal quality assurance.
Relevance: Todav European regulations are frequently lmplemented wlthout the
necessary practlcal measures being avallable to enable effectlve enforcement. lt ls
essenflal to devote adequate financial ancl scientific resources to remedying thls situatlon.
Food control in the European union eight laboratories (as required by international
harmonized protocols) is a time-consuming and
an expensive process. Policy makers often have to
confront a situation in which analwical methods
have not been fully validated and there is a lack
of analytical standards or suitable reference
materials. The European Commission has taken
several initiatives to try to improve this situation.
Since 199'l , the European Commission's Joint
Research Centre (iRC) has given increasing
technical and scientific support to European
regulatory actions in the area of foods, foodstuffs
and other consumer goods. Today, it plays
an important role in method development,
harmonization and validation. ln addition, the
European Standards Measurement and Testing
Programme (SMT) has funded a number of
projects on method development, method
validation, production of reference materials and
dissemination of information to assist food control
laboratories in the food safety and food
ood scares in Eurooe have eroded
consumer confidence in food and the food
supply. This has made the need to ensure
and to demonstrate adeouate food
control measures particularly pressing. There has
been considerable progress in the European
Community towards establishing mutual
recognition in the food-control sector with, for
example, the Additional Measures Food Control
Directive which will be fully implemented in
1998. This requires food control laboratories to
be EN45000 accredited and to participate in
proficiency testing. Whilst the practical means
exist for laboratories to put in place the quality
systems stipulated by this Directive, there are
additional requirements concerning the use of
validated methods and internal quality control
requirements which can be more difficult to meet.
Validation of analytical methods by a minimum of
JC,JCJ
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Since 1991 the
European Commission's
Joint Research Centre
has given increasing
technical and scientific
supporl to European
regulatory actions in
the field of foodstuffs
and other consumer
goods
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The forthcoming
harmonized directive
on mvcotoxins sets the
concentration limit
below the threshold
for which validated
analWical methods are
currentlV available
Laboratories from a
number of Member
States are working
collaborativelV on
mycotoxin testing to
meet this need
Over the next few
months the laboratory
intercomparisons in
four mycotoxin work
areas will be carried
out, covering a total of
ten different food
authenticity sectors. Some examples of these
support activities performed for the benefit of the
European consumer such as validation of test
methods, dissemination of information, testing
methods for controlling food-related fraud and
testing the presence of genetically modified
organisms (CMOs) are illustrated below
validatlon of methods of analysls
for mycotoxins
Mycotoxins are toxic fungal metabolites which
can be present at low levels in a wide range of
foods. Aflatoxin 81 for example is a known human
liver carcinogen and can occur in cereals such as
corn, nuts such as pistachios and dried fruit such
as figs. Different Member States have regulatory
limits which range from 1 to 25 pglkg (ppb) in
specified foods but which will shortly be
harmonized in a Community Directive sefting a
limit at 2 pg/kg for aflatoxin 81 and 4 g&g for total
aflatoxins. However, there are so far no validated
analytical methods for such low concentrations.
Anticipating this difficulty the Standards,
Measurement and Testing (SMT) Programme has
funded a project (CT96-2045) to validate methods
of analysis for aflatoxin 81 and total aflatoxins in
peanut butter, pistachios, figs and paprika;
aflatoxin Mt in liquid milk; ochratoxin A in barley
and roasted coffee and patulin in apple juice. The
project, which began in October '1996, is being
co-ordinated by the UK Ministry of Agriculture,
Fisheries and Food, and involves ten partners from
six Member States including the jRC.
It is important when undertaking collaborative
trials to use materials as close as oossible to real
foods and that are naturally contaminated with the
substances in question. In this project, the naturally
contaminated materials were obtained by taking a
selection of samples from those being analysed as
part of the normal EU commercial import checks.
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The target levels of contamination were obtained
by careful blending of control (uncontaminated)
materials with mycotoxin contaminated foods. lt is
essential to produce homogeneous materials for
intercomparison purposes and considerable effort
goes into grinding, mixing and homogeneity
testing. For example, peanut butter was milled to
ensure that no particulate material remained in the
finished product, and oil separation was avoided
by the addition of lecithin.
Laboratories experienced in the analysis of
mycotoxins covering a range of Member States
from Covernment, academia and industry
sectors have volunteered to participate in the
intercomparisons. Some 16 laboratories are
taking part in the aflatoxin B1 intercomparison.
Laboratory personnel have been assisted in
preparing for the trial by means of a training video
specially filmed for the project, analysing practice
samples and participating in a training Workshop.
Copies of the video (currently in English but also
being translated into French, Cerman and
Spanish) which covers the analysis of aflatoxin 81,
aflatoxin Ml, ochratoxin A and patulin can be
obtained from the authors.
Over the next few months the laboratory
intercomparisons for the four mycotoxin work
areas will be carried out covering a total of ten
different food matrices. On completion of the
trials the validated methods with associated
performance characteristics obtained from the
intercomparisons, will be passed to the European
Committee for Normalization (CEN) for adoption
as European Standards. The CEN Standards will
be recognised by the European Commission as
Official Methods and will thus become available
to food control laboratories as referee methods.
The project will fulfil international requirements
for validation and the methods will also be passed
to the International AOAC (Association of Official
Analytical Chemists) for adoption.
-JJ'-J-J
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Dl$emlnatlon of Informatlon through
the hternet
Some Directives (e.g. Directive 901128 EEC
and amendments) controlling plastic food
packaging materials are complex and detailed.
Their objective is to make sure that only named
substances can be used in the manufacture of
plastics (positive lis$. Additionally the residual
amounts of certain substances in the plastics are
controlled and the amounts permitted to migrate
into food are restricted. Several hundred
frequently obscure substances are controlled
through the positive list and tens of substances
have control limits.
The analysis of food packaging materials and
migration testing are specialized areas which are
outside the normal sphere of anivities for many
food control laboratories. Therc{ore this area in
particular is one where srryort for food control is
essential. The JRC is peparing a European database
of reference substances containing background
information, characteristic spectra and other
physical chemical data in three stages: 1.
Characterization of new substances for use as a
constituent of food contact materials when
technical dossiers are submitted to the Commission
of the European Corrvnunities for authorization,
and comparison with given data;2. Hosting of the
existing reference collection; 3. lmplementation of
solutions for public access to written materials (i.e.
via the World Wide Web) concerning food contact
materials such as Directives, practical guides,
synoptic documents, methods of analysis and
relevant information on substances used in
materials in contact with food. The SMT
Programme has financed a number of projects
involving collection of reference substances and
generation of appopriate spectroscopic data such
as retention indices, nuclear magnetic resonance
(NMR), infra-red and mass spectra. This
information on nprprners and starting substances
,JT-J,J.J
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and on plastics additives has been published in the
form of reference books. Another SMT projea has
generated a number of analytical test methods for
determining residual monomer levels in plastics
and also monomer concentration in food simulants
after migration testing.
This projea carried out jointly by the JRC and
the Central Science Laboratory of the UK Ministry
of Agriculture, Fisheries and Food (MAFF) aims to
disseminate this information as widely as possible
by making it available on an Internet web-site.
The site comprises an introductory page followed
by a searchable listing of all of the substances for
which information is available on the site. For
each substance there is a datasheet page available
giving general information such as CAS number,
chemical structure, molecular weight, regulatory
limits etc. The web-site facilitates rapid
downloading of suitably formatted files. For each
substance, where available, the site provides its
mass, infra-red and NMR spectra ard methods of
analysis. When the database has been completed,
the JRC will have long-term responsibilig for
updating and maintaining it. This oft-forgoften
aspect of the long-term maintenance of a web-site
of European interest is seen as another important
role for a European institution.
Complementing the wetssite is a collection
of reference substances from which the
spectroscopic data were obtained. These
substances are in most cases commercial
samples which cannot be purchased from
normal chemical suppliers. Each has been
spectroscopical ly characterized and pu rity tested
and is being made freely available as an
analytical standard to food control laboratories
and other interested parties. Samples of all new
substances submitted to DGlll for authorisation
are now lodged with the JRC thereby ensuring
this unique reference collection is maintained
in uo-to-date condition.
The IPTS Reoort
801 tl
g"s"
'q^t
\\q
Plastic materials used
for food packaging are
regulated via lists
of often obscure
substances. Migration
testing is highly
specialized and often
beyond the normal
capabilities of food
control laboratories
The JRC is preparing a
European database of
reference substances
for use as food contact
materials with a full
range of technical data
AnalWic data required
bv laboratories will be
made available over
the lnternet in
downloadable form
from a database
maintained by the JRC
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The European Office
for wine, liqueurs and
spirits (BEVABS)
maintains a wine data
bank with a range of
technical data that
can be used to
authenticate wines and
detect adulteration
The JRC is working on
reliable analWic tests
for cocoa-butter
equivalents in
chocolate products
Developlng methods to contrcl food.
related fraud
Adulteration of wine by the addition of sugars
of different botanical origin (i.e. non-grape) to
increase the alcohol content together with
watering of wine are the major problems in the
wine-producing countries. Nuclear magnetic
resonance (NMR) and isotopic-ratio mass
spectroscopy (IRMS) are able to detect such wine
adulteration with a high degree of certaing when
used with information from an appropriate data
bank. The European Office for wine, liqueurs and
spirits (BEVABS) was created at the JRC officially
in 1993 in agreement with DC Vl of the European
Commission. The main purposes of this office are
to provide laboratory services to the EU and its
Member States and to maintain an EU wine
data bank containing the results of NMR
measurements and all information concerning the
location of the vineyard, the gpe and growth of
grape used in authentic European wines since
1991. This work is canied out in collaboration
with specialized laboratories in the EU Member
States (in wine producing countries). The wine
data bank is currently being enlarged by data
on other naturally stable isotopes (13C, 18O). The
NMR method is based on the determination of the
isotopic ratio of deuterium/hydrogen at the
various sites of the ethanol molecule and this
allows the identification of the botanical origin of
sugars present in the original must before
fermentation. Additional information concerning
sugaring and watering can be obtained using the
IRMS method. Both methods can also be used to
analyse liqueurs, spirits, fruit juices and sugars
after fermentation and distillation.
D-malic acid has been claimed not to occur in
nature and is considered to be evidence of
adulteration of fruit juice. Recent work has
demonstrated that this is no longer valid for wines.
The presence of artefacts in the European official
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method for the determination of D-malic acid in
wines has also been found. The JRC and Member
States laboratories are re-examining the official
method and the assessment of the actual levels of
natural D-malic acid in wines.
Due to the harmonization of the chocolate
Directive 731241|EEC there is an urgent need for
improvement or development of methods which
allow quantification of 5% vegetable fats (other
than cocoa bufter) in final chocolate. Due to the
natural variation of cocoa bufters as well as to the
fact that the vegetable fats used in chocolate
production (cocoa butter alternatives) are very
similar in their physical and chemical
composition to cocoa bufter, quantification is a
very difficult task. The lack of reliable analytical
methods to detect and quantify these vegetable
fats (so-called cocoa butter equivalents) in
mixtures containing cocoa butter and in
chocolate, is likely to cause difficulties for the
national authorities responsible for checking
compliance with legislation. The JRC is
developing a suitable analytical method in
collaboration with several laboratories from EU
Member States. Various analytical tools are under
investigation for determination of triglyceride-,
fatty acid-, vitamin-, sterol- and trace element
compositions using multivariate statistical data
evaluation. Preliminary results revealed that a
single analytical method might not be sufficient to
tackle all problems. However, the results already
available from this project are indicating that a
combination of different analytical techniques
might result in an approach that allows
the reliable determination of cocoa butter
equivalents. Final results are expected to be
available at the beginning of 1999.
The Council Directive 741409/EEC on the
harmonization of the laws in the Member States
relating to honey lays down common rules for its
composition and manufacture. The Commission
JJC''
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has adopted a proposal to amend this Directive
providing for the name "honey" to be
supplemented by information referring to the
products' botanical (floral or vegetable) or its
geographical (regional or territorial) origin. The
lack of reliable analytical methods to permit the
identification of the botanical or territorial origin
makes the verification of compliance with
labelling a very difficult task for authorities in the
Member States. The wide variety of plants from
which honey derives and the natural variation of
plants (the influence of climate and geographical
conditions) makes it very difficult to determine the
botanical origin of honey, let alone relate this to a
particu lar geographical location.
Whereas determining isolated parameters such
as 5-hydroxymethyl furfural (HMF), residues,
enzyme activity, moisture, nitrogen and
monosaccharides and disaccharides in honey
does not provide significant information about the
botanical and geographical origin, there
nevertheless seem to be some suitable methods
based on analysis of specific compounds and/or
on multi-component analysis. Mostly, such
methods give an indication of the botanical origin
by investigating flavonoid patterns, pollen
distribution, aroma compounds and special
marker compounds. There are some other profiles
of components which could probably be used for
the detection of the geographical origin (e.9.
oligosaccharides, amino acids, trace elements). A
combination of methods could be a promising
approach for proving authenticity, especially,
when uo-to-date statistical data evaluation
techniques are applied
The JRC is co .linating a proiect on the
development of sur,able analytical methods in this
context. Several participating laboratories from
EU Member States are applying the most
promising combination of methods: analysis of
trace elements, oligosaccharides, amino acids,
J,J,J.J'
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organic acids, DNA analysis, pollen analysis,
flavonoids, aroma compounds and stable isotopic
ratios. The results are expected in spring 1999.
Detection of Genetically ilodified
organlsms (GMo) in Foorls
Council Regulation (EC) No. 1139198
concerning the labelling of certain foodstuffs
produced from genetically modified organisms
(CMOs) indicates that at this stage the presence
in foods and food ingredients of protein or
DNA resulting from genetic modification
constitutes the criterion which best complies
with the requirements set in the Regulation.
There is an urgent need for adequate validated
analvtical methods.
The evaluation of a screening method (direct
method for detection) based on DNA analysis by
means of polymerase chain reaction (PCR) has
been carried out by the JRC. The principle of the
method is the detection of certain promoter and
terminator sequences which are present today in
most GMOs. This method has been validated in
1998 by 29 laboratories in many Member States of
the EU together with Switzerland and the USA.
Standard materials (flours from corn and soy beans)
have been prepared in collaboration with IRMM
Ceel and are already available to the public.
The JRC will investigate in collaboration with
EU Member States' laboratories the applicability
of screening methods and quantitative methods
for GMO determination in processed food.
Beneflts to the consumer from
communlty Fundlng
An article such as this can only present a
snapshot of the range of activities being funded
by the European Community in support of
food control. Large projects such as method
Honey is another
example of a product
whose botanical or
territorial origin is hard
to determtne
Tests are being
developed to detect
the presence of
CM0-derived matter
by means of
their characteristic
sequences in the DNA
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adequate analwic tests
is an essential part of
ensuring compliance
with labelling
regulations, and the
JRC's work is indicative
of the importance of a
Europe-wide approach
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validation for mycotoxins could not be
undertaken without central funding or the
involvement of exoert laboratories from a
number of Member States. The dissemination of
methods of analysis and of spectroscopic data
via the Internet illustrates the essential role that
the JRC can play in the food control sector.
The maintenance of a reference collection of
analytical standards for free distribution to food
control laboratories is another example of a
centralized Community activity. The JRC's role in
consumer protection is wider than just food
safety and the example of co-ordination of
method development for authentication of
honey and chocolate exemplifies a more
speculative research activity, again involving
expert laboratories from a number of Member
States. The consumer benefits in being secure in
the knowledge that food on sale is safe and that
compliance with labelling is being monitored.
These examples illustrate how European
Community funding can translate into real
improvements in consumer protection.
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The Future
Over the next few years there will be increased
harmonization across Europe in the food control
sector. This will translate into the unification of
control measures as well as into continued efforts
to bring food control laboratories in the EU to a
common high standard. At the same time, we can
expect more technological developments in the
food control sector relying on centralized and
rapid information systems to ensure and improve
consumer protection. To make this a reality in the
future, continued support is needed. The role of
the JRC will be pivotal to these developments.
There will be a continued need for co-ordination
of the process of validation of methods of analysis.
In addition, there will be a continued and growing
need for centralized dissemination of support to
the food control sector. Finallv, as we have shown
with the example of CMOs, there will be a
permanent need for rapid central initiatives to
ensure consumer protection, something which
should be maintained as a high priority. f
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Future Technologies, Changing
Consumer oecisions and Labelling
Requirements
Anette Schmitt, VDI-Tz
tssue: Consumer behavlour ls much more volatlle and mu€h less predictable than was the
case 20 years ago. The trend towards lndlvlcluallsation ls increaslngly slgnlflcantly and
ls generatlng Clemand for more dlfferentlated and mofe rapldly changlng pro(luct
informatlon.
Relevance: Wlth the enormous prolif€ration of product alternatlves, lnformatlon has
become ever more hportant to consumers. At the same tlme the value of lnformation
has rlsen, the cost associated with the tlme needed to become well Informed has also
Increased. The prtvate and public beneflts from truth ln labelllng and advertlslng lmply a
conflnued role for EU / government regulatlon of Informatlon about the attrlbutes of
consumer goods.
htroductlon
ne major European supermarket chain
estimates that the number of food items in
a typical retail store increased from 550 in
1954 to more than 10,000 only 40 years
later (Sainsbury's, 1995). Eating in the home has
become more informal and individual and less
predictable (King, 1983). A survey in France
indicated that time spent each day eating at the
table decreased from two hours 30 minutes in
1965 to one hour 20 minutes in 1995 (INSEE).
Aspects of safety, the environment, energy,
performance, quality, services, and information
technology, greater mobility, double incomes,
new sales outlets, longer opening hours and a
larger selection of ready-to-eat products will
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O IPTS - JRC - Seville. 1998
magnify this effect and this has implications
for patterns of technological development.
Biotechnology, separations technology, sensor
technology and modern information technology
are some of the relevant technologies in this
context. Electronic shopping could achieve a
share of about 10% or even 25% in total food
sales in the Western world bv the vear 2005 (1 ).
Virtual shops are already operational on the
Internet, although at the moment many of them
serve primarily as a source of information for the
consumer which - in turn - influences the choices
available to consumers, as well as their
knowledge and buying habits.
Consumers are bombarded with many
different messages which vary over time and
beNveen the interest groups. With the increasing
The IPTS Report
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Consumers are
bombarded with
messages concernlng
health and food
which may often be
presented in a wav that
is too complex or
technical for them to
be able to understand
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use of health as a marketing tool, the amount o1
nutritional information on food labels, for
instance, has sharply increased in recent years
and nutrition labelling has recently become
mandatory on processed foods within the
European Union. Nuhition labelling is based on
the premise that the information presented will
help consumers apply general nutrition principles
and the national nutrient goals when purchasing
food. However, manv consumers neither
understand nor use much of the nutrition
information on food labels when making food-
purchasing decisions. The limited impact of this
information may be attributed to its technical
nature, complexity and numeric form, which
make it difficult and time-consuming to process.
The trouble with labels is that unless they are
properly designed they can create as much
confusion as they convey information. They may
be meaningless without explanation in some
environments and cultures.
ln 1997 the Commission carried out the
Eurobarometer survey to look specifically into
consumer issues. One of the points that came out
strongly from that study was consumers' concern
about the safety of food products. The results
varied between Member States but on average 68
per cent of consumers expressed concern about
food safety. The importance of food safety for
European censumers was further confirmed
during the chat-line Commissioner Bonino
organized on 5 November 1997. Those concerns
have been amplified by many recent stories in the
media which have for example referred to 'mad
cow disease' (BSE), E-coli, Salmonella and
genetically modified organisms in food.
The placing onto the market of genetically
modified products over the last 12 months has,
furthermore, led, in some countries, to even
greater concern amongst consumers and
consumer groups about what they are eating and
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how safe it is. Their concern has focused in
particular on the absence of specific labelling
which could enable informed choices to be made.
In addition, there is unease about the limited
experience with this new technology, with the
perception that current scientific claims may, in
certain cases, be disproved in the future.l
The debate surrounding food labelling centres
on tlvo main aspects; firstly the provision of
consumer information to enable consumers to
make informed choices concerning product
quality and characteristics; and secondly, the
information that could be relevant from a food
safety point of view.
The Commission therefore decided to devote
the 1998 consumer policy information effort to
the issue of food safety and consumer health, and
then to extend their effort into 1 999. In response to
a specific demand from consumers for more
information, in October 1998 the Commission
launched a "European food safety campaign"
which is to run in all 15 European Union
countries. (2) The campaign, whose slogan is
"Food safety is a shared responsibility; the
responsible consumer is informed and active",
aims to inform and educate the consumer.
Consumer associations have been closely involved
in planning and implementing the campaign in
each Member State. lt also ties in with the
Commission's concern to help reduce the
frequency and impact of food poisoning in Europe,
and is particularly innovative in that it provides for
a large measure of decentralisation, with the
creation of national consortia bringing together all
those involved in the food production chain:
farmers, processors/ retailers and consumers.
In the meantime, Iabelling continues to be
one of the most high profile and controversial
aspects of food legislation, even though the
labelling regulations do not apply to food
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Labelling is seen as a
way of allaying fears
concerning issues such
as GMos, for instance,
but unless labels are
well designed they can
simply create more
confusion rather than
convey information
The Commission has
launched a food safety
campaign designed to
engage consumers and
consumer groups in
member states in
creating shared
responsibility for
food safety
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additives, and this can be quite significant. There
have been calls for more detailed information to
be given to the consumer, which would put ever-
increasing pressure on manufacturers, who do
not want to be continually re-labelling their
products and often find it a major challenge to fit
all the information resuired under current
regulatory provisions on the label.
Discussion
Product labels can be of great value to
consumers in allowing them to make more
informed choices between goods and services
offered. For this to function optimally, the EU
should examine and evaluate the effectiveness of
product labelling, and consumers would need to
participate in these investigations if they are to get
the product labelling they want. lf there is clear
evidence that a particular product is likely to be
harmful, or if the available evidence is inadequate
to provide sufficient guarantees of safety then that
would be an issue of concern to European policy
makers. lt is known that there are persistent, deeply
held differences of opinion which engender mixed
reactions among consumers, industry and retailers,
and this may be why one needs to be cautious
about issuing policy statements.
The European Commission's Green Paper on
the general principles of food law in the EU
recognizes that labelling has, thus far, been
approached on a narrowly functional basis. The
question is now being asked as to whether the
right kind of information is being given to
consumers, or whether some of the information
currently required is inappropriate.
Regulators must consider questions such as:
r what role does health play in evaluating the
acceptability of new foods and ingredients?
r in which areas does the consumer need
greater convenience?
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how is it possible to get clear evidence that a
particular product is not likely to be harmful?
how important is sensory perception and what
role do situational factors play?
. how should we handle communications
relating to new technology (and under what
conditions can there be consumer acceptance)?
. how do we pay sufficient attention to
consumers' perception of risk in relation to
food (consumer concerns)?
o what will be the effect of the social undercurrent
demanding that such aspects as the
environment and animal welfare be considered
in the regulation of the production process?
o what are the implications of electronic
commerce for production and distribution and
are consumers ready for this?
. how should labels be designed such that they
would not set up direct or indirect, deliberate
or accidental, barriers to trade, and so that
they can give as immediate an idea as
possible of the content, the effects and the
qualities of a product?
What is certain is that labelling will continue
to be one of the key aspects of food legislation,
and it continues to be imoortant for manufacturers
and retailers to be aware of ootential
developments that could have an impact on the
demand for their products.
From the consumers' point of view, an
appropriate regulatory regime should provide
the confidence that adequate safeguards are in
place, especially where foods using new genetic
technologies are involved. The public first and
foremost wishes to see a full application of the
precautionary principle which would allow
prompt detection of any adverse effects not
currently foreseeable. lt requires that novel
foods, genetically modified organisms and
food ingredients should not be labelled
in a misleading way.
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Labelling continues
to be a controversial
issue. ManV
manufacturers already
find it difficult to fit all
the information
required on their
product label
It is now recognized
that the approach
taken to labelling to
date has been too
narrow and that a
broader range of issues
need to be addressed
so that consumers are
given the information
they want whilst
avoiding the creation
of artificial barriers
to trade
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The European food
safeW campaign could
help improve the
situation by giving
consumers help in
understanding the
information on labels
From industry's point of view labelling
requirements can be prepared, adopted or applied
in such a way that they become trade barriers.
Ways to affix labels, the information required, the
size of the labels, the languages required, when
and how to label are factors which must not be
allowed to become so demanding that they create
unnecessary baniers to trade. Hence, legislation
should be of sufficient flexibilitv so as to be
conducive to innovation and to allow for the
successful commercial development of technology.
outlook
The existence of advice and labelling per se
is. therefore, not a sufficient condition for
consumers' safeW. Consumers must understand
the labels in order to make the recommendations
work. Labelling regulation will only be effective
if linked to a complementary programme of
consumer education and advice and the
restriction of marketing opportunities from
'umbrella claims'.
lmplications for a policy strategy might be to
explore the relative impact of health warnings,
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dietary advice, and negative and positive media
coverage upon the sales of food products.
The new'European food safety campaign'could
help to improve the present situation by supporting
the consumer in understanding the information
given on the labels. The programme's intention is
that: "lf there is a problem, lthe consumer] contacts
the consumer associations and/or competent
authorities. In the majority of Member States, the
approach will be to highlight the importance of
following the instructions given on the labels and
abiding by the basic rules of hygiene." (2)
Hence, whatever the true nature of an optimum
label might be, policy makers must explicitly take
stock of what is attainable in terms of lifestyle,
technology and the economic environment of the
markets. Policy makers, biotechnologists, food
scientists and social scientists will need to work in
close co-operation to share information and to
achieve a befter understanding of the biological
and social processes. However, as the case of
genetically modified food demonstrates, this is no
simple task since its health adverse effects are
oelnS notry o,rpr,.o. f
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Note
1- The Commission has spent the last twelve months reviewing proposals on the issue of how to label
foods and food ingredients derived from CMOs, despite the long-awaited adoption of Regulation (EC)
No. 258/97 on Novel Foods and Novel Food Ingredients. The governments of Austria, Luxembourg, ltaly
and France have responded by a moratorium and banned further imports of genetically modified maize
and other crops unless it can be shown that health and environmental concerns have been adequately
considered. Concern has also been expressed that users of genetically modified products need to be fully
aware of the methods by which these products have been produced so that they can make informed
choices. These same concerns are routinely expressed by a number of Member States in the course
of the decision-making procedures for authorisation of genetically modified organisms under
Directive 901220/EEC.
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Biotechnology and Health Care:
consu mer- Related Aspects
Dimitris Kvriakou and Duncan Cilson
lssue: Blotechnology, In lts many guises, looks set to bring about something of a
revolution ln health-related products over the coming years. Genomics, genetlc
englneerlng and combinatorlal chemlstry together wlll make more products, better
matched to patlents and diseases, come onto the market faster.
Relevance: Blotechnology has the potentlal to produce wide-reaching social and
economic impacts. The accelerated rate of development of new ancl better tests,
treatments and vacclnes is likely to place a strain on health-care insurers and provlders,
as end-users press for access to a wider range of products. Matchlng drugs to patlents
wlll make genetic testlng much more commonplace, and the lssues of prlvacy and
avolding misuse of thls lnformatlon wlll need to be handled appropriately. Finally, we are
llkely to see not Just products that save llves, but products that lmprove the guallty of
llfe, inevitably raising the lssue of who pays and how.
lntrodudion
he ever increasing range of potential
applications opening up to biotechnology
(novel foods, smart materials,
bioremediation, clean fuels, waste-water
treatment, etc.) suggest it is likely to pervade many
aspects of life in the future. The use of genetically
modified organisms (CMOs) in foodstuffs is very
much in the public eye at present and consumers,
in Europe at least, are clearly divided over their
benefits. The impact of food on health has
become deeply ingrained in the contemporary
consciousness, and having been taught that
natural is best it will perhaps be hard for
consumers to accept novelty in the immediate
future. Nevertheless, 'functional foods' (or
nutraceuticals) (see Ihe IPTS Report 20) or other
foods with special nutritional properties resulting
from biotechnology could prove aftractive despite
these qualms. This is particularly if they offer the
possibility of reconciling contradictory desires,
for example low calorie versions of otherwise
fattening foods or cow's milk 'humanized' to
make it better suited for infants. lf, as some
commentators say, there is little or no market pull
for ee retically modified foods outside of these
niches, the pharmaceuticals business is at the
other end of the spectrum, characterized by often
extreme market pull for products which not only
do not exist, but often seem to be little more than
pipedreams. In this area at least some of the
ethical and environmental concerns surrounding
biotechnology tend to be offset by more pressing
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worries about health, although concerns about the
use of animals and possible human applications of
cloning and gene modification are real.
The blotechnologist's toolklt
Biotechnology is the term applied to a range
of new techniques involving the manipulation
of biological material, particularly through the
use of recominant DNA, cell fusion and
other new bioprocessing techniques. Among
these technologies recombinant DNA (rDNA)
technology, or 'gene splicing' as it is sometimes
known, dates back to the 1970s. This basically
involves manipulating DNA in cell-free systems
(i.e. outside of a cell or organism) and then
reintroducing it into the organism thereby
transferring the new genetic information. Early
examples of uses of this technology included the
commercial production of human insulin in 1982
and transgenic, antibiotic resistant tobacco in
1983. Since then new applications have
abounded, the only limitations apparently being
the imagination, concerns about the rights
of animals bred or genetically modified to
develop certain diseases, and fears about the
consequences of unleashing modified organisms
on the environment.
Apart from the efforts of agro-chemicals
companies and research laboratories to produce
new supercrops using rDNA technology, the
highest profile use of these techniques is probably
the human genome project. The HCP is the
continuation of other, less ambitious, gene
mapping and sequencing projects (see Beese, Ihe
IPTS Report lssue 00) which have studied a range
of organisms including bacteria, fruit flies and
mice. The huge investment of effort is, predictably
enough, bringing about advances in the
techniques used, bringing down costs per base
pair and accelerating the rate at which the work
is completed. The most immediate outcome,
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namely the ability to track the genetic origins of
an increasing number of disorders and diseases,
is a cause for concern in some sectors as
no treatment is often available. However, the
quantum leap in our understanding the
underlying mechanisms operating in the human
organism will undoubtedly lead to a wide range of
new preventive and curative treatments.
The detailed genome map will enable
comparison with existing animal genomes
(mouse, fruitful, etc.). This will speed up the
identification of what is specifically human about
the genome, bearing in mind that a large part of
genetic information is common to all living
creatures. This overlap naturally increases when
the organisms are more closely related, but
humans share large amounts of genetic material
with organisms that appear to be very different
from us. lt would seem that once evolution found
a way of performing some basic function it didn't
bother to look for another. After the HCP the
investigation into other genomes will no doubt
continue. Detailed maps of an increasing range of
organisms will make it easier to determine what
models are appropriate for a given system as an
objective measure of similarity with humans will
be available. Using yeast, for example, for testing
during the initial stages of drug development has
huge benefits in cost and rapidity over using
higher organisms, provided it is known that the
mechanisms under investigation are the same.
A further development in the field comes from
combinatorial chemistry, a technique which
simultaneously creates a large array of peptides
(short stretches of protein that are active in
numerous cell functions), thus potentially
speeding up the search for new active ingredients.
Starting with an active lead molecule, this enables
a single chemist to make thousands of different
variations on the original molecule in a short time.
Then these new modified compounds can be
The IPTS ReDort
Biotechnology's ability
to offer hope of new
treatments is likely to
protect it in the case
of pharmaceuticals
applications from much
of the concern that
is being expressed
regarding biotechnology
in the food industry
Cenetic manipulation
began to find
commercially viable
applications in
the'1980s
The genome map of a
human being willopen
up the way to greater
understanding of
a wide variety of
mechanisms involved
in both health
and sickness
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Techniques such as
combinatorial
chemistry shorten
times needed to
identify active
ingredients, thus
bringing drugs to the
trial stage sooner
Many big players are
positioning themselves
so as to be able to
take on the huge
investments anticipatec
in drug development
once as the results of
genome research
become available
Apart from the
possibiliW of
treatments for
headline catching
diseases, many of the
degenerative disorders
Wpical of old age may
be brought more
effective relief, which is
particularly signif icant
in the context of an
ageing population
tested to see if activity has been improved. The
challenges with this technology are in purifying
and identifying the single modified compound
that gives the enhanced activity. However, these
problems are currently being solved by a number
of different methods.
Testing ingredients at present still retains a
large element of trial and enor, but as knowledge
of the underlying mechanisms improves and
comouter models become more accurate at
predicting effects, the time to market, or at least
time to trial, for new pharmaceuticals is likely to
be shortened. Modern drug hunting means finding
a chemical that blocks a specific protein, so the
first step is to locate the target protein responsible
for the disease. Then you need to test through
thousands of chemicals to find the one that turns
the protein off. lf the protein is needed for a virus
to invade a cell, or for a cancer cell to multiply,
then the chemical is a potential new drug.
The blopharmaoeutlcials Industry: larue
and small
The biotechnology and pharmaceuticals
industries are clearly expecting major changes
ahead. In the post-Human Cenome Project era
investments will be huge, but companies know
that the race will be on to find drugs and get
them patented and on the market before their
competitors. Preserving the status quo will not be
an option, thus to prepare themselves companies
are consolidating as never before, and so
presenting authorities with the dilemma regarding
how to balance their distaste for quasi-
monopolistic situations with the needs of the
industry to spread the risk ofthe large investments
needed if the possible rewards are to be reaped.
The complex science involved makes the
issues confusing and potentially frightening for
non-specialists. lnformation and open debate are
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undoubtedly more likely to allay prblic fears in the
longer term than paternalistic recourse to secrecy.
Indeed some of the players in the sector seem also
to think this is the best approach (for example, by
sefting up websites where vknvs both for and
against biotechnology can be dircwsed).
Currcnt Health ileeds and Fsu€s
At the beginning of the century infectious
disease was the leading cause of death in Europe
and the US, accounting br 37o/o of mortalities.
This figure had dropped dramatically to just 1.5%
in 1993 (OECD, 1998). The result is that today,
three out of every four deaths in the developed
world are due to non-comrnunicable diseases.
Diseases of the circulatory systern 
- 
heart attacks
and strokes 
- 
are the largest sirgle cause of death
in developed countries accowrlng br about 46.7
per cent of total deaths, while malignant
neoplasms account {or 21.6 pcr cerf, of deaths
(OECD, 1998). Communicabb diseases remain
a threat, however, and diseases ruch as AIDS
and multi-resistant tuberculosis u€ently need
vaccines and/or treatments that are within the
reach of the world's Boorer countrhr.
However, for the devebfd world in
particular the increasing nrmbcr of elderly
people is, or will become, a rnrjor concern.
According to the WHO, the wrH's population
has been growing at an anilrd rate of 1.7
per cent during the 1990-95 period, but the
population over 65 years is increring at a much
faster pace, by some 2.7 per cent annually. The
implications of this growth will be to bring to the
fore ailments which particularly affect the elderly,
especially those chronic degercrative diseases
which still lack an effective cure, lrch as arthritis,
dementia, cancer, etc. As ever *re question of
improving health in old age is one of both quality
of life and reducing dependence on health and
social services. Appropriate tools b assess the
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outcomes of potential treatments from this
perspective are urgently required in view of
confident predictions that biotechnology will be
offering new diagnostics and genetic therapies in
the near future.
Health In ttre ztst Century
The knowledge and techniques offered by
biotechnology amount to the beginnings of new
approach to drug discovery (and increasingly
substituting discovery by design), production and
delivery. These advances offer hope of treatment
for diseases which have resisted traditional
techniques. The influence of genes has been
identified in various forms of heart disease, breast
and colon cancer, diabetes and arthritis, and the
genes for cystic fibrosis, Duchenne muscular
distrophy, neurof ibromatosis and fragi le X-l inked
mental retardation have been isolated. And these
are just a few of the more than 4000 gene-related
illnesses (OECD, 1998). As research in this field
progresses the genes underlying other diseases
will be uncovered and new insight will be gained
into the processes involved in the commoner
I ife-threatening ai lments.
The ageing population in the world's
wealthier countries is likely to create a situation
in which an increasing number of people require
treatments for chronic, degenerative diseases
(many of which are currently treated only
symptomatically as they lack therapeutic
solutions), whilst the size of the working
population supporting the health care system is
shrinking. Biotechnology may well provide
therapies which strike at the causes of these
ailments, but these are not likely to be cheap.
Moreover, as the population ages, so do voters. lt
may prove politically impossible to keep a lid on
expenditure unless long term planning issues are
tackled in the way they are being looked at for
the case of pension provisions.
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Apart from its role in tackling scourges such as
cancer through the development of innovative new
treatments, the new scenario in the biomedical
industry will probably bring about more subtle
changes. More rapid development times and more
sophisticated ways of designing drugs inevitably
mean that there will be a greater variety of
pharmaceuticals available. This range will include
more treatments for previously untreated diseases,
and also more specific treatments for certain
common diseases. By combining genetic testing
with the prescribing of certain types of medication
it may prove possible to take some of the
guesswork out of the process and match specific
treatments to specific groups of patients. But by
making offering a bewildering range of possible
treatments available for the same disorder, it may
place greater burdens on regulatory authorities,
doctors and finally consumers attempting to sort
out the wheat from the chaff.
cenomlcs n$€6rch: opportunlfies and
challenges
Apart from its likely longer-term impact on
treatment and prevention, research into the
human genome is already giving rise to the
possibility of testing for a range of genetic
predispositions to disease. The principle of
screening the unborn for genetic damage is not
new. A test to detect the chromosonal damage
typical of Down's syndrome has been available
for some time. In the future tests which look for
more subtle variations in a DNA will become
available to detect more of the congenital
abnormalities which are still a maior cause of
death during the first year of life (25-60 liveborn
infants per 1000 are estimated to have congenital
abnormalities, OECD 1 998).
Cenomics also offers the possibility of
screening adults for disorders which they may be
predisposed towards later in life. This will be a
The genes involved in
some of the 4000 0r
more gene-related
illnesses have alreadv
been identified
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promises screening for
an increasing range of
disorders, but will need
to be monitored
carefullv to avoid
inappropriate use or
threatening privacy
The coming decades
ero likolrr fn eoA
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unprecedented growth
in the number of new
pharmaceuticals
available. Some will be
lifesavers, others may
improve the qualiW of
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extend life just that
litlle bit further
valuable technique if it is coupled with adequate
follow-up and preventive programmes, as in the
case of breast cancer tests for example, but is likely
to cause unnecessary distress if there is in fact no
treatment available, such as in the case of tests for
Huntington's Chorea. Discussion of the issues
surrounding testing have been postponed whilst
the spread of the technology has been kept in
check by its price, but already cheap devices are
appearing on the market. The rights and
responsibilities of insurers need to be defined in
this area if overall public interests are to be
balanced with actuarial logic ({or example, in the
BO's insurers in some countries effectively
discouraged voluntary H|V-testing by obliging
policy applicants to disclose whether they had
been tested). The question of who is allowed to be
tested for what will also need to be considered.
Unscrupulous genetic testers may emerge offering
gene tests for predispositions to health problems
related to tobacco or dietary cholesterol.
Consumers who decide not to modify unhealthy
behaviours because as a result of these tests they
consider themselves to be 'immune' may place a
strain on health-care providers. In any event,
genetic testing will produce a new series of
medical data, and it must be ensured that the same
levels of privacy are given as for other medical
data. The need for control in this respect is
aggravated by the relative ease with which
biological samples may be obtained. In the longer
term it may prove necessary to establish legislation
or codes of practice analogous to data protection
regulations governing human biological
specimens. All in all, the way this field shapes up
is clearly a matter of speculation, and it is precisely
this uncertainty over the potential outcomes that
makes a'watch-dog' approach seem prudent.
tife-style drugs and lif€-saving drugs
There is never room for complacency about
the power of medical science to combat disease,
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whether drawing upon biotechnology's armoury
or not. AIDS and BSE-related encephalitis serve
as a reminder of the complex and refractory
nature of some illnesses. Multi-resistant
tuberculosis demonstrates that enemies that
once seemed to have been conquered can
indeed fight back. Nevertheless, medical science
has made developments which have resulted in
greater longevity, and against backdrop of
increasing expectations, this can add up to
unexpected demands on health-care systems
designed in an epoch when simply saving lives
was difficult enough.
Recent experience shows that in matters
concerning health demand expands to match the
treatments available, whereas of course budgets
do not. The coming decades are likely to see
unprecedented growth, in the number of new
pharmaceuticals available. Some will be
lifesavers, others may improve the quality of life
for sufferers of chronic conditions or extend life
just that little bit further. Yet others may treat
conditions, such as baldness or limited stature in
children, which may not even be universally
classified as disorders.
Clearly, as drugs become available so people
will demand them. Moreover, recent history
suggests they will demand them with ever
increasing militancy. Systems in which the
authorities issue lists of what is and is not
covered by the health-care system are likely to
be overloaded by sheer numbers of products
to approve (or 'disapprove'), and they risk
turning themselves into the object of constant
attack from one pressure group or another
demanding treatment for 'its' problem. Coherent
frameworks are likelv to be needed to avoid
conflicts arising or to channel them when they
d, in such a way that all stake holders have the
opportunity to express their views in a
structured way.
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Society is sensitive about substances which burdens on health care providers may well force
alter the functioning of the human organism. At a rethink of their approach to 'minor' ailments. At
one end of the spectrum this is reflected in the same time an increasing number of
legislation which prohibits the use, or at least treatments, including some for conditions which
possession, of certain substances (notably may not universally be considered appropriate
psychotropic drugs), but further down the scale it mafters for medical practitioners to deal with may
is also reflected in health-care policies which set impose the need for a more logical approach to
limits on what ailments they are willing to treat. what is allowable. However, those electing the
The biomedical revolution will not alter the easy option of allowing nothing, or as little as
fundamentals of this situation, just as information possible, will have to confront ever more militant
technology did not invent information. 'consumers' of these treatments and the problem
of how to control cross border 'trade' and
The possibility of expensive treatments shady clinics setting up on the territory of more
emerging for life{hreatenin6 illnesses imposing liberal neighbourt. 5
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lnternet text indexes
and search engines
have been a key factor
in the growth in
populariW of the World
Wide Web, but this
growth has meant that
the amount of
information these
services provide is
often overwhelming
for users
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The Supply of lnformation to the
consufft€1": when More is nctually Less
loannis Maghiros, lPfS
lssue: consumers, at the centre of an efficient electronlc market, are Increaslngly uslng
novel hternet-based technologles ln order to ldentlfy hlgh quallw products, better
servlces and prlces. sellers, also maklng use ofthe latesttechnologlcal advances, present
thelr merchandlse on the Internet profltlng from onllne-coliected detalled consumer-
speclflc lnformatlon.
Relevance: Too much lnformatlon to scan through may lronlcally make selectlng more
dlfflcult. Targeted advertlslng ralses guestlons of prlvacy rlghts and moral concern about
the use of Informaflon. Measures ought to be studied that would educate the consumer
early on, as to how to combat lnformatlon Overload, as well as keep an eye on key actors
ancl the way ln whlch they mlght explolt thelr domlnant market posltlon.
Introductlon 'intelligent agents', etc.). The result is the problem
of being inundated with information, somewhat
like trying to quench your thirst with a fire hose.
This, howevet also signals a business opportunity
for the developers of novel filtering techniques.
The gradual commercialization of the lnternet
places the online-user cum consumer at centre
stage and empowers him/her by means of (mostly
free) software tools allowing him/her to determine
which oroducts and services to view and
purchase from among those available on the basis
of their value for money. Sellers are also
benefiting from the electronic marketplace
through the creation and running of virtual shop
fronts, which are easy to set-up and cheap to run.
One approach to the problem of managing
customer communication is to use 'intelligent'
,J .J -J ,J "J
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he proliferation of information available
on the lnternet as a result of the increase
in the number of online users and the
number of interconnected nodes has
triggered the need to develop indexed information
and new sofNvare tools for searching distributed
indexes. Self-proclaimed gatekeepers have
developed indexes and search engines which
have greatly boosted WWW usage. Spiders and
Crawlers, i.e. software robots that travel the Web
continuously index all the text they find (current
estimates calculate some 70 million on-line
pages) and general-purpose software interfaces
help end-users identify specific information
sources by a variety of means (e.g. subject
directories, free-text search, advertising banners,
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data files called cookiesl that store customer
specific information. Consumer-goods companies
use consumer identity attributes (eg. age,
sex, online decisions) as well as purchasing
information to provide tailored information to
their target markets. In the light of the dominant
revenue models in this emerging market, the
variety of specialized tools that convey
information enabling "best buys" to be selected
and the impact that this flood of information will
have on the consumer, this article seeks to draw
attention to some of the policy challenges ahead.
Marketlng Consumer Proalucts and
Services on the InternEt
The ease of setting up shop on the Internet and
the promise of attractive profits has enticed a
whole host of players. These use various
mechanisms for revenue raising, including
advertising, pay-per-view and subscription. Of
these, the advertising model involves other
companies placing advertisements on Web sites,
which are usually run by content providers for
whom advertising is usually their main or only
source of revenue. Once considered an
inappropriate use of the Internet, Forrester
Research, a consultancy firm, signals that
expenditure on advertising on the Internet will
increase l0jold between now and the vear 2003
($1300M, 1997 and $15000M,2003). However,
this still represents less than 5 percent of
total advertising expenditure worldwide. The
advantage of the advertising model lies in the
development of tools that allow companies to
learn what the world's increasingly sophisticated
and sceptical consumers are thinking and respond
quicker than ever before, thus forging stronger
relationships with consumers. Most on-line
advertising today takes the form of banner ads, the
wide, shallow rectangles often seen at the top or
bottom of Web pages, which if clicked with a
mouse take the user to the advertiser's Web site.
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But these banners are being largely dismissed as
being too small and simply too ineffective. Novel
advertising systems are currently being designed
including transactional ads and rich-media ads2.
Another model is that of offering services
through subscription. This is attractive to content
providers because it guarantees revenue. lt is
a 'push' technology model, similar to the
broadcasting model governing today's media
world. This system is more suited to information
management professionals who need very high
levels of information to perform effectively. lt is
primarily for this type of users that tools have been
developed to enable filtering and automatic
rejection of unsolicited information. Consumers
requiring more customized and personalized
services are less likely to support this model. A
variant of this system enabling access by a
broader set of consumers, is the pay-per-use
model. The strong points of this model are on the
one hand, the cost-effective customization of
products according to individual preferences
addressing individual consumers' needs and
greater control over copyright, and on the other,
payment of individual pieces of information on
an ad hoc basis. Nevertheless its diffusion is
dependent on the widespread adoption of
a micro-payments infrastructure, and this is
currently not available. Hybrid models
incorporating any combination of the above are
likely to become profitable in the near future 
-
such as for example the try-before-you-buy
model. Technology is strongly influencing the
development of products, pricing models and
strategies for the future.
Technologlcal solutlons to enhance
consumens' knowledge
Companies spending millions on advertising
on the Internet are investing in web-based
technologies that enable direct personalized
The IPTS Report
For retailers the
Internet offers low
start-up and running
costs for their
virlual shop and
unprecedented ability
to profile and target
their actual and
potential customers
Advertising is
becoming the
dominant revenue
source on tne
Internet, and part of its
attraction for sellers is
the feedback it gives
on the reactions of the
world's increasingly
sophisticated and
sceptical consumers
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Portals, a recent
evolution of gateways,
and electronic agents,
are being developed
to enable lnternet
navigation by filtering
information
Using meta-
information is a more
sophisticated approach
to information retrieval
and one which offers
more possibilities
for intelligent
customization
marketing of products and services. Cateways are
web sites which host search engine indexes. They
enable pass-through access to an array of Web
sites either through general-purpose free-text
search mechanisms or by providing a hierarchical
thesaurus of sites for a broad range of audiences,
based on demographic, key-subject and
geographic interests. Portals, a recent evolution of
gateways, enable Internet navigation, accessing
a broad range of content and services, and
communication with others online. In general
they offer some services for free so that they
may then profit by identifying distinct user
communities and suggesting suitable services
for a fee.
lmproved information sharing between buyers
and sellers helps lower the cost of logistics and
promotes rapid, just-in-time delivery and reduced
inventory. Many systems have therefore been
developed to enable this type of bilateral
transactions aimed at lowering buyers' search
costs and sellers' marketing overheads (e.9.
PriceWatch, ComputerESP and Travelocity). Other
systems addressing a variety of information needs,
such as preferred lists of Web sites depending
on user profiles3, software auction tools4 and
automated price negotiatorr5 hru. also been
developed commercially. While currently the
emphasis is on tools tracking the best available
price on offer, there is a growing preference for
tools able to compare quality attributes, which is
beneficial for the market at large (offering quality
to buyers and less of a price war for sellers).
Obviously enough, retrieval procedures based
on keyword indexes are not sufficient given
the volume of content available. Research
into systems that provide meta-information
(information on information) is ensuring that these
systems are elaborate enough to present diverse
values and interests. Another important way in
which sites may be customized is through
December 1998
localization, where cultural and linguistic
distinctions will lead to the emergence of regional
content sites, especially in Europe, which will
become dominant audience attractions. The
search for, and retrieval of, public information is
also pertinent in the drive towards a more
empowered consumer. While European
coroorations have taken the lead in Web
localization, successfully adapting products,
brands, and prices to meet local market variations
(in Europe, 80% of corporate sites are
multilingual, with English the preferred second
language) few U.S. companies address the needs
of their international audience. Although
localization is expensive, adding between 10% to
60% to a site's development costs, localized sites
generate more traffic, longer visits, and greater
customer satisfaction.
The lmpact on the consumer
Consumer-goods companies, technology
companies, content providers, portals and Web-
based intermediaries across the globe are rapidly
trying to address the problem of communication
with the consumer via the Web. But as technology
makes it easier for companies to gather
information on consumers these must also accept
the responsibility that comes with that
information.
Consumers are becoming more concerned
about threats to their personal privacy as
companies are increasingly able to process data
related to personal details and purchasing habits.
The current attitude to user-orofile data collected
is that it is too valuable to disregard but not likely
to be used for the time being as no one really
knows how to process it (although research on
data mining techniques is on the increase). ln
general consumers are willing to share personal
information if companies provide them with clear
benefits (usually price discounts). The solution to
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this perceived data-privacy problem therefore
resides in controlling the flow of this information
in a way that should in principle be both
transparent to the consumer and traceable.
The mechanisms used differ between
countries: European countries ensure the
protection of electronic data through regulation,
whereas the United States Covernment
encourages agreements or codes of conduct
between industry and consumer representatives.
Directive 95l46lEC, the European directive to be
implemented6 from 25 October 1998, provides
for a high degree of protection within the
European Union, for the treatment of data of a
personal nature. lt also comprises an external
chapter submitting exchanges of private data with
third countries to strict criteria, which has caused
some concern to governments and economic
players in some third countries. This difference in
practices gives rise to the question of whether
companies will be required to maintain two web
sites to cater for consumers on different
continents. lt could well be that the WTO with its
wide membership and binding dispute settlement
procedures, may be an appropriate setting in
which further progress on data protection could
be made. The OECDT could also play a major
role in this context.
The World Wide Web Consortium (W3C), the
international industry consortium which acts as a
monitoring body for the Web8, has developed a
mechanism to support consumer data protection.
The Platform for Privacy Preferences Project (P3P)
has been designed to promote privacy and trust
on the Web by enabling service providers to
disclose their information-processing practices,
and enabling individuals to make informed
decisions about the collection and use of personal
information relating to them. Special P3P software
agents installed on client machines transact on
behalf of individuals and reach agreements with
J'J,J'
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other P3P softvvare agents installed on service
provider machines about the collection and use of
personal information. Transactions are allowed to
proceed when a match is found between web site
practices regarding application of relevant laws
and principles of data protection and privacy
and user preferences. In addition, there are
various other suggestions, concerning voluntary
regulation of data collection and use, being
considered in the debate on both sides
of the Atlantic.
Beyond the risk of individual loss of privacy,
there is also the risk of tampering with the
information provided. Since gateways provide the
tools that enable users to filter unwanted
information, there is concern over their control of
the electronic directories and therefore content.
Whilst the risks of this happening are minimal,
there is however a race for more visible and
better-positioned data on a portal type of web-site.
The money to be made out of having the blessing
of the gatekeeper seems to be tempting enough for
Netscape, the browser-software company, to
prefer to compete in this market as a portal.
Finally, the collection of personal data from
children, a growing category of online users,
should be carefully addressed9.
Challenges
The proliferation of information on the
electronic networks/ both public and private, has
given consumers the choice of a wide variety of
products and services and sellers an even wider
array of marketing tools. Thus a situation which
was apparently beneficial for all concerned has
given rise to an information overload, i.e. a
situation in which users receive too much
unwanted information, as with more users on-line
there is now so much more content available and
so many more ways to access content. Challenges
The IPTS Report
Some users may not
object to their personal
details and purchasing
habits being recordec
by Internet retailers if
this means benefits for
them, such as user-
profile-matching
services or discounts
for loyal customers
Different national
approaches to the
issue of privacy
worldwide run counter
to the globalizing
tendency of the Web
and global forums
could be an
appropriate setting for
debate on this issue
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The challenge now is to
maintain the beneficial
elements of knowledge
generation while at the
same time decreasing
the olethora of
unsolicited information
Among other things,
solutions will focus on
ever more intelligent
filtering at the user
end and more
intelligently structured
data 
- 
including meta-
information 
- 
at the
provider end
European users
need to be equipped
with the necessarv
understanding of how
to build uo criteria with
which to judge from a
European, diversiW-
exploiting perspective
arise out of the desire to maintain the beneficial
elements of knowledge generation while at the
same time decreasing the plethora of unsolicited
information.
. Automatic Filtering Systems: a solution
already developed is to use tools that exclude
'non-information' either by aiming at defining
the subject searches more precisely or by
limiting search scope more objectively. In this
case more research is needed in the fields of
Information Retrieval, Artificial Intelligence
and Relevance Theory. Private individuals
(unlike professionals) are more prone to
constantly changing their online behaviour
and so require a new generation of intelligent
agents to combat information overload.
Contextual information: another solution,
recently applied to Web propagated data, is to
base consumer trust on mediated information
sources thus highlighting the weight of
contextual information or meta-information;
initially denoting "information about
information" it is now interpreted as
"machine understandable information, about
information on the web". Meta-information
will facilitate searching, by enabling authors to
describe their documents in ways that search
engines, browsers and Web crawlers can
understand their content. In this case more
research is required into computer-friendly
knowledge representation languages, sector-
specific vocabularies and filter definitions.
Data-privacy Protection Protocols: Novel
advertising techniques and better-focused
consumer advice (distinguished by more tools
to enable the identification of the right product
at the right price) are a welcome evolution of
the market for consumer products. In spite of
that, the lack of knowledge and control over
the use of the oersonal information that these
disclose, denotes the need for specific data
protection regulation. Consumers should be
fully aware of Web site privacy policies for the
December 1998
market to function well beyond initiatives
like P3P by W3C. In this case and on top of
agreeing on an internationally acceptable
regulatory framework, some kind of controlled
licensing/permittingl 0 on service providers
should be exercised so that implementation of
stated practices is supervised for the benefit of
the consumer. In addition, by regulating
liabilities of the intermediaries, concerns over
the lack of means of controlling the integrity
of the broker and/or the gatekeeper may be
abated.
. Educaiing the Consumer: Finally, the
proliferation of information sources is likely to
bring about an increasing number of cases
where conflicting information will be
obscuring the decision making process.
Individuals seem to require more information
processing skills and the consciousness of
personal responsibility over decisions to be
made. In addition, consumers should be
educated to protect themselves from activities
that make poor use of their time and
intelligence. Thus it will be necessary to
acquaint the consumer early enough, with the
necessary understanding of how to build up
his/her own set of criteria with which to judge
- 
a European multi-lingual, multi-choice
system. The overall objective is to enhance a
consumer's critical ability to make more
'intelligent' choices and thus help in the
functioning of a primarily information market.
concluslons
As technology makes marketing to individuals
possible and the European e-commerce market
increases its turnover, it seems likely that there
will be a transition from an lnternet revenue
model based on access fees to one based on
transaction and advertising revenues. Moreover,
individuals are empowered by such technology
integration to identify quickly and simply what is
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relevant, thus giving birth to an "intelligent
consumer". Choice-enabled consumers through
new devices, tools, and services will continually
be pressing for better deals, making it more
difficult for businesses to create long lasting
relations with this gpe of consumers.
Commercial organizations will attempt to
forge profitable relationships with customers and
they are likely to use extracted customer-specific
information for this purpose. Hence the growing
baftle over the control of portals that are able to
build comprehensive user-profiles by offering
services for free in order to raise and maintain
consumer confidence. Consumers will also have
to be educated to cultivate their own selection
system and not adopt ready-made recipes. In this
case consumers and their associations will treat
intermediaries and service providers that do not
readily adopt a clear data processing policy with
increasing suspicion. The result may be a radical
rethinking of how products are marketed sold and
distributed on the Internet. At the same time, more
and better technology will enable consumers to
search and select avoiding being overloaded with
unwanted information. f
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Itlotes
1- Whenever a user accesses a Web page for the first time, the server assigns a specific identification
number (cookie) to the user and transmits a data file that resides on the user's PC and gets updated
whenever the user visits the Web page again with basic data attributes revealing details about the
customer's environment.
2- Transactional ads are designed to create a two-way flow of information, enabling interaction (eg.
WAC from First Virtual); rich media ads include audio-enhanced banners and streaming audio-video
advertising.
3- The Direct Hit Popularity Engine, is a search engine that analyses Internet selections made by a user,
during his online time and then by comparing with known patterns from other users, presents a list of
preferred sites for the specific user.
4- Onsale.com auctions last minute unsold airline tickets.
5- Tete-e-Tete, developed by Mll negotiates purchase on behalfof buyers and sellers.
6- The implementation of this Directive by Member States has been delayed, in order to allow more time
for negotiations between the Commission and the U.S. administration to reach an agreement.
7- The latest OECD Conference, in Ottawa, Ontario, 7-10 October 1998, is another likely forum for
promoting consumer protection-issues, due to the simultaneous presence of world government
authorities and representatives of both consumers and the business world.
B- The W3C was founded in October 1994 ro lead the World Wide Web to its full potential and is jointly
hosted by the Massachusefts Institute of Technology Laboratory for Computer Science IM|T/LCSI in the
United States; the Institut National de Recherche en Informatique et en Automatique INRIA] in Europe;
and the Keio University Shonan Fujisawa Campus in Japan.
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9- In a report to the U.S. Congress on Privacy Online it is stated that of all Web sites that appeal to
children, 90% of them collect personal information and about half of them do not disclose what they do
with iU parental consent for children under 13 years of age could be a solution to this problem.
10- eTRUST is a seal service, a "trustmark" jointly developed by the Electronic Frontier Foundation (EFF),
the online free-speech advocates and CommerceNet the not-for-profit e-commerce organization.
References
. Kyriakou, D., Maghiros, 1., Multimedia lnformation Sociery May 1997.
. Platform for Privacy Preferences Project http://www.w3.orgfiVNOTE-P3P10-principles
o Cuttman, R., Moukas, A., Maes, P., Agent-mediated Electronic Commerce: a suNey, MIT Media Lab
hft p://ecommerce.media.mit.edu
. Clobalisation and Localisation strategies: http://www.forrester.com/press/pressre/980811.htm
. Smith, D., Computerizing Computer Science, Communications of the ACM, September 1998.
r The OECD latest Conference on E-commerce, http://rvrvw.ottawaoecdconference.com
r Netscape's Netcentre site is an Internet portal http://home.netscape.com/netcenter/
o Yahoo! Inc. is the first online navigational guide to the Web, http://www.yahoo.com
Related URL's: VADz is a form of Java applet developed by the Transactional Media Unit at First
Virtual Holdings http://www.firstvirtual.com/services/vtag.html/; Altavista Search Service
http://altavista.digital.com/; The Price Watch web-site http.//www.pricewatch.com/; ComputerESP is
the engine of Cnet's shopper online shop, http://www.shopper.com/; The BizRate Guide maintains a
merchant's reputation database from information provided by users of their systems,
hftp://www.bizrate.com/display.p|; Priceline is a buying service that lets you name your price; the
buyer specifies product requirements and a price he/she is willing to pay and collects sellers' offers
http://www.priceline.com/; The lnternet Auction Web site http://www.onsale.com/; The Internet online
travel agency Travelocity allows customers to set their preferred price, hftp://rvww.travelocity.com/
Contact
loannis Maghiros, IPTS
Tel.: +34 95 448 82 8l, fax: +3495 448 83 39, e-mail: ioannis.maghiros@irc.es
'',JJ,J
@ IPTS - JRC - Seville. 1998
No 30 December 1998 The IPTS Report
The IPTS is one of the eight institutes of the Joint Research Centre of the EU Commission. lts remit
is the observation and follow-up of technological change in .its broadest sense, in order to
understand better its links with economic and social change. The lnstitute carries out and co-
ordinates research to improve our understanding of the impact of new technologies, and their
relationship to their socio-economic context.
The purpose of this work is to support the decision-maker in the management of change pivotally
anchored on Sfi developments. In this endeavour IPTS enjoys a dual advantage: being a part ofthe
Commission IPTS shares EU goals and priorities; on the other hand it cherishes its research institute
neutrality and distance frqm the intricacies of actual policy-making. This combination allows the
IPTS to build bridges betwen EU undertakings, contributing to and co-ordinating the creation of
common knowledge bases at the disposal of all stake-holders. Though the work of the IPTS is
mainly addressed to the Commission, it also works with decision-makers in the Eurooean
Parliament, and agencies and institutions in the Member States.
The lnstitute's main activities, defined in close cooperation with the decision-maker are:
1. Technology Watch. This activity aims to alert European decision-makers to the social, economic
and political consequences of major technological issues and trends. This is achieved through the
European Science and Technology Observatory (ESTO), a European-wide network of nationally
based organisations. The IPTS is the central node of ESTO, co-ordinating technology watch 'joint
ventures' with the aim of better understanding technological change.
2. Technology, employment & competitiveness. Civen the significance of these issues for Europe
and the EU institutions, the technology-employment-competitiveness relationship is the driving
force behind all IPTS activities, focusing analysis on the potential of promising technologies for job
creation, economic growth and social welfare. such analyses may be linked to specific
technologies, technological sectors, or cross-sectoral issues and themes.
3. Support for policy-making. The IPTS also undertakes work to supports both Commission services
and other EU institutions in response to specific requests, usually as a direct contribution to
decision-making and/or policy implementation. These tasks are fully integrated with, and take full
advantage of on-going Technology Watch activities.
As well as collaborating directly with policy-makers in order to obtain first-hand understanding of
their concerns, the IPTS draws upon sector actors' knowledge and promotes dialogue between
them, whilst working in close co-operation with the scientific community so as to ensure technical
accuracy. In addition to its flagship IPTS Report, the work of the IPTS is also presented in occasional
prospective notes, a series of dossiers, synthesis reports and working papers.
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The |PTS Report is published in the first week of every month, except for the monlhs of Jonuory ond Augusl. h is edited in English
ond is currently ovoiloble ot o price of S0 fCU per yeor in four longuoges; English, French, Germon ond Sponish.
The Europeon Science ond Technology Observotory Network (ESTOI:
IPTS - JRC - Europeon Commission
W.T.C., lslo de lo Cortuio s/n,E 41092, Saillo, Spoin
vl.: +34-95-448 82 97; Iox: +34-95-448 82 93; e-moil: iptlsecr@[rc.es
. ADIT - Agence pour lo Diffusion de l'lnbrmotion Technologique - F
. CESI - Centre for Exploitotion of Science ond Technology - UK
. COTEC - Fundoci6n poro lo Innovoci6n Tecnol6gico ' E
. DTU - University of Denmork, Unit of Technology Assessment - DK
. ENEA - Directorote Studies ond Strobgies - |
. INEII - Instituto Nocionol de Engenhorio e Technologio Indushiol - P
. ITAS - Insfitut fur Technikblgenobschcikung und Systemonolyse - D
. NUTEK - Deportment of Technology Policy Studies - S
o OSI - Observotoire des Ssiences et des Techniques - F
o SPRU - Science Poliry Reseorch Unit - UK
. TNO - Centre br Technology ond Policy Studies - NL
. VDI-TZ - Technology Centre Future Technologies Division - D
. VITO - Flemish Instituc for Technology Reseorch - B
. VTf - Group for Technology Studies - FIN
Ip:-
\oab
o.
oxt
\o
@II
mz
r)
